Search for: "Board of Directors of Pharmaceutical Product Development, LLC" Results 21 - 40 of 44
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Nov 2009, 4:51 am
(Innovationpartners)   Germany Ferrero v FIFA (in World Cup trade mark dispute) – 1:0 says the German Bundesgerichtshof (IPKat)   India WIPO Director General pledges support for India’s visually impaired community (WIPO) Delhi High Court on working of patents and S 107A(b) Strix Limited v. [read post]
1 Feb 2023, 9:05 pm by renholding
  The Microsoft/OpenAI transaction illustrates the potential need for well-established tech leaders to look to bolt-on M&A as a source of product innovation and expansion. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
Charles Duan (@Charles_Duan) is Director of Technology and Innovation Policy at the R Street Institute.From vaccines to ventilators to diagnostic tests, technology has dominated response strategies to the ongoing COVID-19 pandemic. [read post]
1 Jan 2020, 10:35 am by Cynthia Marcotte Stamer
For more information about this or other labor and employment developments, please contact the author Cynthia Marcotte Stamer via e-mail or via telephone at (214) 452 -8297. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
14 Feb 2018, 2:57 pm by Kevin LaCroix
Each year our Year in Review comments on significant securities-related decisions by the Supreme Court, federal appellate courts and district courts, notes key developments in SEC enforcement, and summarizes significant rulings in state law fiduciary litigation against directors and officers of public companies. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on… [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will… [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz)   Global – Copyright Illegal art: (Patry Copyright Blog),     Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will need to… [read post]
1 Jun 2010, 8:16 am by law shucks
The largest nonpracticing entity is Intellectual Ventures Management LLC, started by a former Microsoft Corp. executive, with from 10,000 to 15,000 groups of patents, according to PatentFreedom. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
25 Jan 2024, 6:06 pm by The White Law Group
  EQT Exeter: EQT Exeter Real Estate Income Trust  Investment Focus: Stabilized, income-oriented U.S. commercial real estate, primarily targeting supply chain industrial properties and offices leased to research and development tenants in healthcare, biotech, and pharmaceuticals. [read post]
13 Mar 2009, 4:00 am
– Need for business and government to understand role of IP (IPEG)   Global - Trade Marks / Brands New record for international trade mark registrations in 2008 but signs of slowdown at year end and possible negative annual income (WIPO) (IP Frontline) (Intellectual Property Watch) (Law360) Coca-Cola is no longer the world’s most valuable brand (IAM) WTO session tackles details of future register of GI products (Intellectual Property Watch) Can a house mark or… [read post]
9 Nov 2009, 6:01 am
Doctors generally don't tell people that they're prescribing drugs pitched to them by pharmaceutical salespeople for unapproved treatments, says Peter Lurie, deputy medical director of Public Citizen, a Washington-based public interest group. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
27 Mar 2009, 7:20 am
(Technology Transfer Tactics)   Global - Trade Marks / Brands Starfish and spiders – trade mark hazards for decentralised, non-hierarchical organisations (Property, intangible)   Global - Patents Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Agreement to simplify international patent classification system (WIPO) (IPKat) (Competitive Info) Concerns voiced at WIPO over potential… [read post]
31 Oct 2009, 4:06 pm by admin
Environmental Protection Agency Region 5 has reached an agreement with J&J Cores LLC on alleged clean-air violations at the company’s secondary aluminum production facility at 2237 Oxford Township Road, Newcomerstown, Ohio. [read post]